With an expanding portfolio of intellectual property and interdisciplinary technical expertise, we represent the new face of biotechnology and bioengineering. By employing a systems-based approach, our technical solutions involve drug delivery combinations including "tunable" nano-carriers, engineered peptides, re-formulated pharmaceuticals, and as appropriate, recombinant proteins. To that end, we are developing solutions that reflect research efforts in computer science, systems biology, physics, molecular biology, pharmacology, protein engineering and biotechnology. It is our belief that by having a broad range of technology and scientific expertise at our disposal, we will have the resources required to efficiently address current or evolving clinical demands.